Free Trial
NASDAQ:CDIOW

Cardio Diagnostics (CDIOW) Stock Price, News & Analysis

Cardio Diagnostics logo
$0.01 +0.00 (+20.41%)
As of 11/4/2026 03:44 PM Eastern

About Cardio Diagnostics Stock (NASDAQ:CDIOW)

Advanced

Key Stats

Today's Range
$0.0118
▼
$0.0119
50-Day Range
$0.0064
▼
$0.0177
52-Week Range
$0.01
▼
$0.07
Volume
35,239 shs
Average Volume
37,819 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cardio Diagnostics Holdings, Inc. develops technology-enabled tests intended to support the prevention and detection of cardiovascular disease. Its platform combines genetic and epigenetic biomarkers with artificial intelligence to assess cardiovascular health.

The company’s offerings include Epi+Gen CHD, a test designed to assess coronary heart disease risk, and PrecisionCHD, a test intended to help evaluate patients with symptoms that may indicate coronary heart disease. The tests are offered as laboratory-developed tests in the United States.

Cardio Diagnostics was founded in 2017 and is based in Chicago, Illinois. Its work focuses on making cardiovascular assessment more personalized by combining molecular data with clinical information.

AI Generated. May Contain Errors.

Receive CDIOW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDIOW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

CDIOW Stock Analysis - Frequently Asked Questions

Cardio Diagnostics' stock was trading at $0.0259 on January 1st, 2026. Since then, CDIOW stock has decreased by 54.4% and is now trading at $0.0118.

Shares of CDIOW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/05/2026
Next Earnings (Estimated)
12/02/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CDIOW
CIK
1870144
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$14.45 thousand
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:CDIOW) was last updated on 11/4/2026 by MarketBeat.com Staff.
From Our Partners